IGF-1 LR3 dosage chart
This summary table compares available dose amounts and schedules by administration route.
| Route | Dose | Frequency & duration |
|---|---|---|
| Injectable | 20–50 mcg | Daily or training days · 4–6 wk |
IGF-1 LR3 dosage by administration route
IGF-1 LR3 injectable dosage
Reported-use amounts for IGF-1 LR3 are 20–50 mcg per administration, daily or training days, for 4–6 wk. Reported injectable amounts are 20–40 mcg initially, 50–80 mcg at an intermediate level and 80–100 mcg at a higher level, once daily after exercise for 4–6 weeks. Step intervals and a validated human titration schedule are not specified.[9][10]
IGF-1 LR3 is a modified IGF-1 analogue with different binding characteristics from native IGF-1. Changes in insulin sensitivity and blood glucose are central considerations with systemic exposure.[1][2][3][9]
Frequency and timing
Morning or after a workout is the listed injection timing; some patterns use training days rather than every day.[4][1][2][9]
Cycle length and breaks
Injectable: 4–6 wk. A standard break interval between courses is not established.[9]
IGF-1 LR3 dosage calculator
Convert your chosen IGF-1 LR3 amount into volume and U-100 syringe units. Adjust the inputs to match your vial and preparation.
IGF-1 LR3 safety and side effects
Side effects and long-term safety
Systemic IGF-axis exposure can involve glucose symptoms and fluid shifts. Human dose-response, immunogenicity, long-term metabolic effects and product interchangeability remain poorly characterized.[5]
Route-specific dosing limits
Glucose control, growth-factor-sensitive conditions, injectable product quality and anti-doping restrictions require separate attention. Reported-use injectable schedules and additional protocol patterns are not established human treatment regimens or approved product instructions.[5][10][9]
Common IGF-1 LR3 dosage questions
Is there a standard human dose of IGF-1 LR3?
A transferable human dose for IGF-1 LR3 has not been established. A product strength or reminder amount does not establish a treatment regimen.[9]
What dosage is listed for IGF-1 LR3?
Does IGF-1 LR3 have a standard cycle or break interval?
Injectable: 4–6 wk. A standard break interval between courses is not established.[9]
Sources
Show citationsHide citations
- [1]IGF-1 LR3 does not promote growth in late-gestation growth-restricted fetal sheep.Am J Physiol Endocrinol Metab, 2025 Jan 1. animal.
- [2]Attenuated glucose-stimulated insulin secretion during an acute IGF-1 LR3 infusion into fetal sheep does not persist in isolated islets.J Dev Orig Health Dis, 2023 Jun. animal.
- [3]Action of long(R3)-insulin-like growth factor-1 on protein metabolism in beef heifers.Domest Anim Endocrinol, 1999 May. animal.
- [4]Search Drugs@FDA for IGF-1 LR3U.S. Food and Drug Administration. database query.
- [5]The 2026 List of Prohibited Substances and MethodsWorld Anti-Doping Agency, 2026. regulatory.
- [6]Compounding and the FDA: Questions and AnswersU.S. Food and Drug Administration. official guidance.
- [7]Bulk Drug Substances Used in Compounding Under Section 503A of the FD&C ActU.S. Food and Drug Administration, 2026-05-14. official guidance.
- [8]Bulk Drug Substances Used in Compounding Under Section 503B of the FD&C ActU.S. Food and Drug Administration, 2025-01-07. regulatory.
- [9]PepFlow peptide cheat sheet — reported-use and product-orientation reference (not clinical research)PepFlow. reference catalog.
- [10]IGF-1 LR3 — Everything Peptide reported protocol (educational reference, not clinical evidence)Everything Peptide. reference catalog.


